Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway

Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway

US Patent 11400133 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Methods of engineering transferrin receptor binding polypeptides2024
Methods of engineering transferrin receptor binding polypeptides2024
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods t2024
Fusion proteins comprising enzyme replacement therapy enzymes2024
Engineered transferrin receptor binding polypeptides2023
Engineered polypeptides2023
Fusion proteins comprising an engineered knottin peptide and uses thereof2022
SPD-1 variant# FC fusion proteins2022
SPD-1 variant# FC fusion proteins2022
SPD-1 variant# FC fusion proteins2022